THE WIRE
What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Key
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.
- METAMeta Platforms, IncThe Chief Legal Officer sold $974K of stock under a 10b5-1 plan.$974K−5.9%Form 4 ↗
- METAMeta Platforms, IncThe Chief Technology Officer sold $4.9M of stock under a 10b5-1 plan.$4.9M−5.9%Form 4 ↗
- FTHAForefront Tech Holdings Acquisition CorpMaterial agreement and officer or director change.0.0%8-K 1.01 ↗
- ENPHEnphase Energy, IncA director sold $23.2M of stock.$23.2M−10.7%Form 4 ↗
- STISolidion Technology IncOfficer or director change and shareholder vote.−7.7%8-K 5.02 ↗
- LILAKLiberty Latin America LtdRegulation FD disclosure.−2.8%8-K 7.01 ↗
- LILAKLiberty Latin America LtdRegulation FD disclosure.−2.8%8-K 7.01 ↗
- NWNNorthwest Natural Holding CoA director sold $77K of stock under a 10b5-1 plan.$77K+0.3%Form 4 ↗
- SEERSeer, IncThe VP Financial Planning Analysis sold $4K of stock.$4K−1.8%Form 4 ↗
- HTFLHeartflow, IncThe Chief Medical Officer sold $4.2M of stock under a 10b5-1 plan.$4.2M+4.6%Form 4 ↗
- NKTRNektar TherapeuticsThe President & CEO sold $15K of stock.$15K−7.2%Form 4 ↗
- NKTRNektar TherapeuticsThe Chief R&D Officer sold $7K of stock.$7K−7.2%Form 4 ↗
- ALXOAlx Oncology Holdings IncPassive stake of 5% or more (13G), filed by Coastlands Capital.+3.9%13G ↗
- LASRNlight, IncThe Chief Accounting Officer sold $7K of stock under a 10b5-1 plan.$7K−14.3%Form 4 ↗
- LEOBny Mellon Strategic Municipals, IncSaba Capital Management, a 10% owner, bought $431K of stock.$431K−0.5%Form 4 ↗
- VIKViking Holdings LtdThe EVP, Business Development sold $7.4M of stock under a 10b5-1 plan.$7.4M−1.0%Form 4 ↗
- LIDRAEye, IncA director bought $25K of stock.$25K−7.4%Form 4 ↗
- UTHRUNITED THERAPEUTICS CorpThe EVP & General Counsel sold $4.7M of stock under a 10b5-1 plan.$4.7M−0.8%Form 4 ↗
- KURAKura Oncology, IncThe Chief Commercial Officer sold $3K of stock under a 10b5-1 plan.$3K−6.0%Form 4 ↗
- DSMBny Mellon Strategic Municipal Bond Fund, IncSaba Capital Management, a 10% owner, bought $42K of stock.$42K−0.2%Form 4 ↗
- TEMTempus AI, IncThe EVP, Chief Legal Officer sold $422K of stock.$422K−9.3%Form 4 ↗
- TEMTempus AI, IncThe CEO and Chairman sold $1.1M of stock.$1.1M−9.3%Form 4 ↗
- TEMTempus AI, IncThe Chief Financial Officer sold $446K of stock.$446K−9.3%Form 4 ↗
- TEMTempus AI, IncThe CEO, Data sold $646K of stock.$646K−9.3%Form 4 ↗
- TEMTempus AI, IncThe Chief Accounting Officer sold $97K of stock.$97K−9.3%Form 4 ↗
- KNTKKinetik Holdings IncSadek Wahba, a 10% owner, sold $1.8M of stock.$1.8M−2.1%Form 4 ↗
- MXFMexico Fund IncSaba Capital Management, a 10% owner, bought $344K of stock.$344K−0.9%Form 4 ↗
- AAPLApple IncThe SVP, GC and Government Affairs sold $846K of stock under a 10b5-1 plan.$846K−1.9%Form 4 ↗
- TNGXTango Therapeutics, IncA director sold $80K of stock under a 10b5-1 plan.$80K−4.3%Form 4 ↗
- MGNIMagnite, IncA director sold $501K of stock.$501K−6.9%Form 4 ↗
- LEELEE ENTERPRISES, IncA director bought $121K of stock.$121K−0.8%Form 4 ↗
- GFNew Germany Fund IncSaba Capital Management, a 10% owner, bought $27K of stock.$27K−1.6%Form 4 ↗
- MATXMatson, IncThe Senior Vice President sold $321K of stock.$321K−1.8%Form 4 ↗
- CRAICra International, IncThe President and CEO sold $1.5M of stock under a 10b5-1 plan.$1.5M+1.7%Form 4 ↗
- BMRNBiomarin Pharmaceutical IncThe EVP, Chief R&D Officer sold $303K of stock.$303K−1.6%Form 4 ↗
- HFROHighland Opportunities & Income FundSaba Capital Management, a 10% owner, bought $67K of stock.$67K−2.9%Form 4 ↗
- CPAYCorpay, IncRegulation FD disclosure.
Corpay Invests Alongside TPG to Acquire BILL Transaction Advances Strategic Rotation into Corporate Payments Transaction expected to be accretive to 2027 EPS Company will host an investor call at…
−1.0%8-K 7.01 ↗ - FBIOFortress Biotech, IncThe President, CEO & Chairman bought $253K of stock.$253K+7.3%Form 4 ↗
- FBIOFortress Biotech, IncThe Chief Financial Officer bought $88K of stock.$88K+7.3%Form 4 ↗
- LCTXLineage Cell Therapeutics, IncA director bought $771K of stock.$771K−5.9%Form 4 ↗
- IMDXInsight Molecular Diagnostics IncNeal C Bradsher, a 10% owner, bought $6.0M of stock.$6.0M+18.7%Form 4 ↗
- RDZNRoadzen IncA director bought $17K of stock.$17K−1.7%Form 4 ↗
- WATTEnergous CorpA director sold $3K of stock under a 10b5-1 plan.$3K−9.2%Form 4 ↗
- PALProficient Auto Logistics, IncA director bought $78K of stock.$78K−3.2%Form 4 ↗
- PALProficient Auto Logistics, IncA director bought $84K of stock.$84K−3.2%Form 4 ↗
- APPFAppfolio IncThe Chief Executive Officer sold $443K of stock under a 10b5-1 plan.$443K−0.4%Form 4 ↗
- MAGNMagnera CorpResults of operations.+3.7%8-K 2.02 ↗
- LUNRIntuitive Machines, IncAn officer sold $26K of stock.$26K−10.3%Form 4 ↗
- GRXGabelli Healthcare & WellnessRx TrustSaba Capital Management, a 10% owner, bought $11K of stock.$11K−1.1%Form 4 ↗
- JYNTJOINT CorpCharles E Jobson, a 10% owner, bought $379K of stock.$379K−3.7%Form 4 ↗